ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 841

Effect of Partial and Complete Proteinuria Recovery in Lupus Nephritis On Long Term Outcomes

Zahi Touma1, Murray B. Urowitz2, Dominique Ibanez2 and D. D. Gladman3, 1Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 2Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 3Division of Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: proteinuria and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Clinical Aspects and Treatment I: Renal

Session Type: Abstract Submissions (ACR)

Background/Purpose:

The identification of partial proteinuria recovery (PPR) of  ≥ 50% allows for the detection of an additional number of patients who improve their proteinuria on standard of care treatment.  The long term outcome of patients with  ≥ 50% PPR at 1 year is not well studied.

To determine the prognostic value of PPR and complete proteinuria recovery (CPR) at 1 year on long term outcomes compared to patients who did not recover proteinuria  ≥ 50% on standard of care therapy.

 

Methods:

All active lupus nephritis (LN) patients registered at a large lupus clinic from 1970-2011. Proteinuria was defined as >0.5g/24 hours based on a 24 hour urine collection. Patients with proteinuria and at least one of the urinary sediments (hematuria, pyuria or casts) present at entry into the study and persistent on 2 consecutive visits were enrolled.

 

CPR was defined as proteinuria <0.5g/24 hours based on SLEDAI-2K. PPR was a decrease of ≥ 50% in the level of proteinuria from baseline as defined by SLEDAI-2K responder index-50 (SLEDAI-50-RI). Not recovered was defined as less than 50% recovery.  Proteinuria recovery was identified if present on 2 consecutive visits within 1 year.

 

The long term outcomes (death, eGFR<15, dialysis or kidney transplant, SLICC Damage Index (SDI)>0, SDI>3) occurring after the identification of proteinuria related to LN at entry into the study were studied. The mean time to long term outcome was determined

Proportional hazard models were used to determine the hazard ratio (HR) for long term outcomes for the different recovery definitions.

 

Results:

217 patients (81.8% female) were identified. At 1 year: 45 patients achieved PPR, 48 CPR and 124 not recovered.

Long term outcomes: eGFR< 15 was identified in 14.3% of the patients, dialysis or kidney transplant in 12.8%, .18% of the patient died and 56% developed damage (SDI>0) with 30.7% with SDI >3.

The mean time to event from 1st visit in the study were:  7.0 ± 8.3 years for death (n=39),  3.7 ± 3.7 years for eGFR< 15 (n=30), 5.5 ± 6.0 for dialysis or kidney transplant (n=20), 3.6 ± 5.6 years for SDI>0 (n=75) and 6.1 ± 7.3 years for SDI>3 (n=57).

Achieving a PPR at 1 year protects from the development of eGFR<15; HR=0.29. Achieving a CPR at 1 year protects from the development of eGFR<15 (HR=0.25), accrual of damage with SDI>3 (HR=0.23) and none with CPR at 1 year subsequently went on to dialysis or transplant. (Table 1).

 

Conclusion:

Achieving complete recovery from proteinuria in patients with active lupus nephritis at 1 year from the onset of lupus nephritis protects against comorbidities including end stage kidney disease, dialysis and transplant, organ damage and death. Nonetheless, achieving at least partial recovery in proteinuria, ≥ 50%, at year 1 from the onset of lupus nephritis protects against the development of  eGFR<15.

 

 

 

 

 

 

 

Table 1. Time to development of event in patient who achieved CPR and PPR at 1 year compared to patients without proteinuria recovery

 

Outcomes

PPR

HR(p-value)

CPR

HR (p-value)

Death

0.88 (0.75)

0.35 (0.05)

eGFR <15

0.29 (0.04)

0.25 (0.02)

Dialysis or Kidney Transplant

0.42 (0.17)

No event

SDI>0

1.05 (0.86)

0.70 (0.22)

SDI>3

0.73 (0.35)

0.23 (0.002)

Atherosclerotic events

1.07 (0.93)

0.84 (0.79)

 

 

 


Disclosure:

Z. Touma,
None;

M. B. Urowitz,
None;

D. Ibanez,
None;

D. D. Gladman,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effect-of-partial-and-complete-proteinuria-recovery-in-lupus-nephritis-on-long-term-outcomes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology